Abstract
The study investigated a panel of lysosomal enzymes in the liver and kidney tissues in alloxan-induced diabetes in the mouse. The mice were divided into six experimental groups receiving 10% alloxan at a dose of 50 and 75 mg/kg over a period of four, eight, and twelve days; each group was compared with controls receiving 0.9% NaCl. The findings were that diabetes induced by both doses of alloxan was accompanied by significant increases in the lysosomal activities of acid phosphatase and the glycosidases investigated: β-glucuronidase, β-galactosidase, β-glucosidase, and N-acetyl-hexosaminidase. The lysosomal enzyme activity in both liver and kidney cells peaked 12 days after onset of diabetes for most enzymes, at the time when hyperglycemia and hyperinsulinemia already started abating after their peak at 8 days into the course of diabetes. The enzyme activity was in most cases higher with the higher dose of alloxan and thus higher level of glycemia. Lysosomal enzymes degrade glycoconjugates, the molecules that are present in the basement membrane of endothelial cells where they contribute to capillary wall stability. Thus, enhanced activity of these enzymes could presage the progression of diabetic microangiopathy, atherosclerosis, and the development of microvascular complications.
References
Al-Attas OS, Al-Daghri NM, Alfadda AA, Abd-Alrahman SH, Sabico S (2011) Blood thiamine and its phosphate esters as measured by high-performance liquid chromatography: levels and associations in diabetes mellitus patients with varying degrees of microalbuminuria. J Endocrinol Invest 35(11):951–956
Barrett AJ, Heath MF (1977) Lysosomal enzymes. In: Dingle JT (ed) Lysosomes. A Laboratory Handbook. North-Holland Publishers, Amsterdam/New York/Oxford, pp 19–145
Beaufay H (1972) Methods for isolation of lysosomes. In: Dingle JT (ed) Lysosomes. A Laboratory Handbook. North-Holland Publishers, Amsterdam/New York/Oxford, pp 1–30
Bhimji S, Godin DV, McNeill JH (1985) Biochemical and functional changes in hearts from rabbits with diabetes. Diabetologia 28(7):452–457
Chang AY, Noble RE, Wyse BM (1977) Streptozotocin-induced diabetes in the Chinese hamster. Biochemical and Endocrine Disorders. Diabetologia 13(6):595–602
Dell’aquila AM, Ellger B (2013) Perioperative glycemic control: what is worth the effort? Curr Opin Anaesthesiol 26(4):438–443
El-Demerdash FM, Yousef MI, El-Naga NI (2005) Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem Toxicol 43(1):57–63
Faure AM, Werder J, Nyström L (2013) Reactive oxygen species responsible for beta-glucan degradation. Food Chem 141(1):589–596
Fushimi H, Shibata M, Tarui S (1980) Glycosidase activities in the liver and kidney of hereditary diabetic mice. J Biochem 87(3):941–949
Gambaro G, Venturini AP, Noonan DM, Fries W, Reg G, Garbisa S, Milanesi C, Pesarini A, Borsatti A, Marchi E (1994) Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int 46(3):797–806
Gilinsky AS, Kirk AF, Hughes AR, Lindsay RS (2015) Lifestyle interventions for type 2 diabetes prevention in women with prior gestational diabetes: a systematic review and meta-analysis of behavioural, anthropometric and metabolic outcomes. Prev Med Rep 24:448–461
Grötsch H, Hropot M, Kief H, Klaus E (1986) Enzymuria in streptozotocin-diabetes rats. J Clin Chem Clin Biochem 24(8):533–539
Hamer I, Van Beersel G, Arnould T, Jadot M (2012) Lipids and lysosomes. Curr Drug Metab 13(10):1371–1387
Heltianu C, Robciuc A, Botez G, Musina C, Stancu C, Sima AV, Simionescu M (2011) Modified low density lipoproteins decrease the activity and expression of lysosomal acid lipase in human endothelial and smooth muscle cells. Cell Biochem Biophys 61(1):209–216
Hinohara Y, Takanashi S, Nagashima R, Shioya A (1974) Glucuronic acid pathway in alloxan diabetic rabbits. (I). Urinary excretion of metabolites related to the glucuronic acid pathway. Jpn J Pharmacol 24(6):869–878
Kido Y (2013) Progress in diabetes. Rinsho Byori 61(10):941–947
Kirschke H, Wiederanders B (1984) Methoden zur Aktivitätsbestimmung von Proteinasen (Methods for determining proteinase activity). In: Kongress und Tagungsberichte der Martin-Luther-Universität, Halle-Wittenberg, Halle; pp. 11–17 (Article in German)
Kołątaj A, Śliwa-Jóźwik A, Jóźwik A (2001) The lysosomal cell complex as a stress response indicator. Anim Sci Pap Rep 19(3):177–192
Krischer JP, Cuthbertson DD, Yu L (2003) Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 88(1):103–108
Kumari K, Sahib MK (1993) Susceptibility of different rat tissue to non-enzymatic protein glycosylation in experimental diabetes. Indian J Exp Biol 31(2):194–195
Kutryk MJ, Pierce GN, Dhalla NS (1987) Alterations in heart and serum lysosomal activities in streptozotocin-induced diabetes. Basic Res Cardiol 82(3):271–278
Lowry OH, Rosebrough NJ, Farr L, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–266
Mandrup-Poulsen T (2013) Type 2 diabetes mellitus: a metabolic autoinflammatory disease. Dermatol Clin 31(3):495–506
McAnuff MA, Omoruyi FO, Morrison EY, Asemota HN (2003) Hepatic function enzymes and lipid peroxidation in streptozotocin-induced diabetic rats fed bitter Yam (Dioscorea Polygonoides) steroidal sapogenin extract. Diabetologia Croat 32(1):17–23
McAuliffe AV, Fisher EJ, McLennan SV, Yue DK, Turtle JR (1996) Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminuria. Diabet Med 13(8):758–763
Miralles JM, Velasco J, Villabona V, Sanchez-Bernal C, Perez N, Corrales JJ, Garcia-Diez LC, Villar E (1993) Prospective study of the enzymatic activities in urine of N-acetyl-beta-D-glucosaminidase, alpha-D-mannosidase, alpha- and beta-D-glucosidases, alpha-L- and beta-D-fucosidases, and beta-D-galactosidase in type I diabetes mellitus with early nephropathy. J Diabetes Complications 7(3):99–203
Mohanam S, Bose SM (1983) Influence of streptozotocin- and alloxan-induced diabetes in the rat on collagenase and certain lysosomal enzymes in relation to the degradation of connective tissue proteins. Diabetologia 25(1):66–70
Mohanam S, Bose SM (1984) Influence of streptozotocin- and alloxan-induced diabetes on the metabolism of glycosaminoglycans. Acta Diabetol Lat 21(3):203–210
Oshima Y, Isogai S, Mogami K, Ohuchi H, Ohe K (1994) Protective effect of heparin on renal glomerular anionic sites of streptozotocin-injected rats. Diabetes Res Clin Pract 25(2):83–89
Panin LE, Kliment’eva TK, Maianskaia NN (1982) Effect of glucocorticoids and catecholamines on the state of the tissue lysosomal apparatus in rabbits with experimental diabetes. Probl Endokrinol (Mosk) 28(1):70–73
Perkisas S, Vandewoude M (2016) Where frailty meets diabetes. Diabetes Metab Res Rev 32(Suppl 1):261–267
Platt FM, Boland B, van der Spoel AC (2012) The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol 199(5):723–734
Rohrbach DH, Martin GR (1982) Structure of basement membrane in normal and diabetic tissue. Ann N Y Acad Sci 401:203–211
Stroev EA, Chugunova LG, Dubinina II (1993) Activity of lysosomal enzymes in diabetes mellitus patients along with diffuse enlargement of the thyroid gland. Vopr Med Khim 39(2):35–36
Takumi T, Kodama S, Takahashi T, Matsuo T (1985) N-acetyl-beta D-glucosaminidase activity in serum, kidney and liver of streptozotocin-induced diabetic rat. Enzyme 34(3):166–473
Waters PJ, Flynn MD, Corrall RJM, Pennock CA (1992) Increases in plasma lysosomal enzymes in Type 1 (insulin-dependent) diabetes mellitus: relationship to diabetic complications and glycaemic control. Diabetologia 35(10):991–995
WHO (2012) World Health Statistics 2012. WHO Press, Geneva
Witek B, Król T, Kołątaj A, Ochwanowska E, Stanisławska I, Slewa A (2001) The insulin, glucose and cholesterol level and activity of lysosomal enzymes in the course of the model alloxan diabetes. Neuro Endocrinol Lett 22(4):240–244
Witek B, Ochwanowska E, Kołątaj A, Baranowska D, Król T, Rafay J (2004) Insulin-induced changes of proteolytic activity of the lysosomal enzymes. Neuro Endocrinol Lett 25(1-2):83–86
Witek B, Fronczyk W, Jóźwik A, Walczak M, Kamińska A, Kołątaj A (2014) The effect of dietary protein level on selected degradative enzymes activity of hepatocytes cellular subfractions in experimental mice. Anim Sci Pap Rep 32(3):269–283
Zhao T, Lu X, Davies NM, Gong Y, Guo J, Zhang H, Li Z, Hong J, Fu G, Li P (2013) Diabetes results in structural alteration of chondroitin sulfate in the urine. J Pharm Pharm Sci 16(3):486–493
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Witek, B. et al. (2017). Activities of Lysosomal Enzymes in Alloxan-Induced Diabetes in the Mouse. In: Pokorski, M. (eds) Clinical Research Involving Pulmonary Disorders. Advances in Experimental Medicine and Biology(), vol 1040. Springer, Cham. https://doi.org/10.1007/5584_2017_102
Download citation
DOI: https://doi.org/10.1007/5584_2017_102
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74091-1
Online ISBN: 978-3-319-74092-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)